Nature's Sunshine Products Current Ratio 2006-2018 | NATR

Nature's Sunshine Products current ratio from 2006 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Nature's Sunshine Products Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-12-31 $0.11B $0.07B 1.60
2018-09-30 $0.11B $0.06B 1.72
2018-06-30 $0.10B $0.06B 1.81
2018-03-31 $0.10B $0.06B 1.85
2017-12-31 $0.10B $0.05B 1.91
2017-09-30 $0.11B $0.06B 1.95
2017-06-30 $0.10B $0.07B 1.51
2017-03-31 $0.10B $0.07B 1.47
2016-12-31 $0.10B $0.06B 1.50
2016-09-30 $0.11B $0.06B 1.76
2016-06-30 $0.11B $0.06B 1.79
2016-03-31 $0.11B $0.06B 1.77
2015-12-31 $0.10B $0.05B 1.91
2015-09-30 $0.11B $0.05B 2.03
2015-06-30 $0.11B $0.05B 2.08
2015-03-31 $0.12B $0.06B 2.12
2014-12-31 $0.12B $0.06B 2.09
2014-09-30 $0.14B $0.06B 2.33
2014-06-30 $0.14B $0.06B 2.32
2014-03-31 $0.15B $0.06B 2.29
2013-12-31 $0.15B $0.07B 2.17
2013-09-30 $0.15B $0.07B 2.23
2013-06-30 $0.15B $0.06B 2.47
2013-03-31 $0.15B $0.06B 2.43
2012-12-31 $0.15B $0.06B 2.37
2012-09-30 $0.14B $0.06B 2.19
2012-06-30 $0.13B $0.06B 2.12
2012-03-31 $0.13B $0.06B 2.00
2011-12-31 $0.13B $0.07B 1.85
2011-09-30 $0.12B $0.07B 1.82
2011-06-30 $0.13B $0.07B 1.79
2011-03-31 $0.12B $0.07B 1.70
2010-12-31 $0.11B $0.07B 1.64
2010-09-30 $0.11B $0.06B 1.67
2010-06-30 $0.10B $0.07B 1.53
2010-03-31 $0.10B $0.07B 1.50
2009-12-31 $0.10B $0.07B 1.49
2009-09-30 $0.11B $0.08B 1.45
2009-06-30 $0.11B $0.08B 1.40
2009-03-31 $0.10B $0.08B 1.34
2008-12-31 $0.11B $0.08B 1.39
2008-09-30 $0.11B $0.08B 1.32
2008-06-30 $0.11B $0.09B 1.32
2008-03-31 $0.11B $0.08B 1.37
2007-12-31 $0.11B $0.08B 1.42
2007-09-30 $0.00B $0.00B 0.00
2007-06-30 $0.00B $0.00B 0.00
2007-03-31 $0.00B $0.00B 0.00
2005-12-31 $0.10B $0.07B 1.40
2005-09-30 $0.11B $0.05B 1.99
2005-06-30 $0.10B $0.05B 2.12
2005-03-31 $0.10B $0.05B 1.88
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.176B $0.365B
Nature's Sunshine Products manufactures and markets through direct sales encapsulated and tableted herbal products, high quality natural vitamins, and other complementary products. In addition to the United States, the Company has operations in Japan, Mexico, Central America, South Korea, Canada, Dominican Republic, Venezuela, Ecuador, Peru, the United Kingdom, Columbia, Brazil, Thailand, Israel, Singapore, Malaysia, Indonesia, the Philippines, Australia, Hong Kong, Taiwan, Russia, Ukraine, Latvia, Lithuania, Kazakhstan, Mongolia, Belarus, China, Poland, Germany, Austria, Norway, Sweden, the Czech Republic and the Netherlands. The Company also has exclusive distribution agreements with selected companies in Argentina, Australia, Chile, New Zealand, and Norway.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $48.799B 32.43
Takeda Pharmaceutical (TAK) Japan $28.404B 10.51
Grifols (GRFS) Spain $13.029B 15.92
Ionis Pharmaceuticals (IONS) United States $10.222B 31.70
Sage Therapeutics (SAGE) United States $7.722B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.333B 10.50
Neurocrine Biosciences (NBIX) United States $7.116B 458.65
Catalent (CTLT) United States $6.500B 27.21
Nektar Therapeutics (NKTR) United States $5.533B 8.83
Tilray (TLRY) Canada $4.962B 0.00
United Therapeutics (UTHR) United States $4.461B 7.59
Taro Pharmaceutical Industries (TARO) Israel $4.241B 13.65
FibroGen (FGEN) United States $4.125B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.695B 0.00
Portola Pharmaceuticals (PTLA) United States $2.448B 0.00
PTC Therapeutics (PTCT) United States $2.256B 0.00
USANA Health Sciences (USNA) United States $1.886B 15.82
Ironwood Pharmaceuticals (IRWD) United States $1.871B 0.00
Heron Therapeutics (HRTX) United States $1.860B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.795B 0.00
Aerie Pharmaceuticals (AERI) United States $1.782B 0.00
Xencor (XNCR) United States $1.753B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.725B 21.49
Endo (ENDP) Ireland $1.661B 2.56
Pacira Pharmaceuticals (PCRX) United States $1.659B 143.54
Madrigal Pharmaceuticals (MDGL) United States $1.647B 0.00
Zogenix (ZGNX) United States $1.622B 0.00
Tricida (TCDA) United States $1.412B 0.00
Corcept Therapeutics (CORT) United States $1.387B 20.15
Theravance Biopharma (TBPH) Cayman Islands $1.319B 0.00
Esperion Therapeutics (ESPR) United States $1.160B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.045B 0.00
TherapeuticsMD (TXMD) United States $0.991B 0.00
Radius Health (RDUS) United States $0.973B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.881B 0.00
CannTrust Holdings (CTST) Canada $0.794B 0.00
Akebia Therapeutics (AKBA) United States $0.757B 0.00
ChemoCentryx (CCXI) United States $0.753B 0.00
ArQule (ARQL) United States $0.677B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.617B 0.00
Dermira (DERM) United States $0.606B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.605B 0.00
Odonate Therapeutics (ODT) United States $0.597B 0.00
Forty Seven (FTSV) United States $0.586B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.565B 0.00
GlycoMimetics (GLYC) United States $0.557B 0.00
Collegium Pharmaceutical (COLL) United States $0.486B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.467B 24.11
Corbus Pharmaceuticals Holdings (CRBP) United States $0.462B 0.00
KalVista Pharmaceuticals (KALV) United States $0.431B 0.00
Siga Technologies (SIGA) United States $0.427B 0.00
Translate Bio (TBIO) United States $0.419B 0.00
Aptorum Group (APM) China $0.419B 0.00
Flexion Therapeutics (FLXN) United States $0.410B 0.00
TCR2 THERAPTCS (TCRR) United States $0.407B 0.00
OptiNose (OPTN) United States $0.390B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.381B 0.00
Mast Therapeutics (SVRA) United States $0.371B 0.00
ImmunoGen (IMGN) United States $0.366B 0.00
CASI Pharmaceuticals (CASI) United States $0.320B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.303B 0.00
Karyopharm Therapeutics (KPTI) United States $0.292B 0.00
Minerva Neurosciences (NERV) United States $0.284B 0.00
Aclaris Therapeutics (ACRS) United States $0.282B 0.00
Lannett Co Inc (LCI) United States $0.281B 2.61
Harpoon Therapy (HARP) United States $0.273B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.267B 9.90
Xeris Pharmaceuticals (XERS) United States $0.257B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.246B 0.00
Molecular Templates (MTEM) United States $0.245B 0.00
Dova Pharmaceuticals (DOVA) United States $0.240B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.240B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.237B 0.00
Calithera Biosciences (CALA) United States $0.237B 0.00
Concert Pharmaceuticals (CNCE) United States $0.233B 0.00
Rafael Holdings (RFL) United States $0.225B 0.00
Aldeyra Therapeutics (ALDX) United States $0.224B 0.00
MEI Pharma (MEIP) United States $0.219B 0.00
Galectin Therapeutics (GALT) United States $0.216B 0.00
Opexa Therapeutics (ACER) United States $0.208B 0.00
Ardelyx (ARDX) United States $0.208B 0.00
Affimed (AFMD) Germany $0.207B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.202B 0.00
Majesco Entertainment (PTE) United States $0.196B 0.00
Recro Pharma (REPH) United States $0.185B 0.00
Jounce Therapeutics (JNCE) United States $0.184B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.184B 0.00
ElectroCore (ECOR) United States $0.180B 0.00
AgeX Therapeutics (AGE) United States $0.178B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.175B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.174B 0.00
Redhill Biopharma (RDHL) Israel $0.171B 0.00
Ocular Therapeutix (OCUL) United States $0.171B 0.00
Neon Therapeutics (NTGN) United States $0.169B 0.00
Aratana Therapeutics (PETX) United States $0.168B 0.00
Tyme Technologies (TYME) United States $0.153B 0.00
IMV INC (IMV) Canada $0.149B 0.00
MediWound (MDWD) Israel $0.146B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.142B 0.00
Aquestive Therapeutics (AQST) United States $0.140B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.133B 0.00
ProNAi Therapeutics (SRRA) Canada $0.119B 0.00
Iterum Therapeutics (ITRM) Ireland $0.113B 0.00
Neos Therapeutics (NEOS) United States $0.111B 0.00
China SXT Pharmaceuticals (SXTC) China $0.109B 0.00
Cardiome Pharma (CORV) Canada $0.103B 0.00
Champions Oncology (CSBR) United States $0.102B 0.00
Natural Alternatives (NAII) United States $0.101B 9.83
Zafgen (ZFGN) United States $0.096B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.095B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.092B 0.00
Adherex Technologies (FENC) United States $0.092B 0.00
Nivalis Therapeutics (ALPN) United States $0.091B 0.00
DURECT (DRRX) United States $0.090B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.090B 0.00
Bio Blast Pharma (ENLV) Israel $0.089B 0.00
Infinity Pharmaceuticals (INFI) United States $0.088B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.085B 0.00
SCYNEXIS (SCYX) United States $0.085B 0.00
Avenue Therapeutics (ATXI) United States $0.083B 0.00
Otonomy (OTIC) United States $0.078B 0.00
Genocea Biosciences (GNCA) United States $0.078B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.064B 0.00
Capnia (SLNO) United States $0.064B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.058B 0.00
CTI BioPharma (CTIC) United States $0.057B 0.00
Forward Pharma (FWP) Denmark $0.055B 0.00
Melinta Therapeutics (MLNT) United States $0.053B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.051B 0.00
India Globalization Capital (IGC) United States $0.050B 0.00
Bio-Path Holdings (BPTH) United States $0.046B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.046B 0.00
Lipocine (LPCN) United States $0.046B 0.00
Mannatechorporated (MTEX) United States $0.044B 0.00
KemPharm (KMPH) United States $0.043B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.040B 0.00
BioLineRx (BLRX) Israel $0.039B 0.00
ContraFect (CFRX) United States $0.038B 0.00
Heat Biologics (HTBX) United States $0.036B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.036B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.034B 0.00
HANCOCK JAFFE (HJLI) United States $0.032B 0.00
IsoRay (ISR) United States $0.029B 0.00
Shineco (TYHT) China $0.029B 4.85
Achieve Life Sciences (ACHV) United States $0.027B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.027B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.026B 3.47
PharmAthene (ALT) United States $0.025B 0.00
Biomerica (BMRA) United States $0.024B 0.00
Onconova Therapeutics (ONTX) United States $0.024B 0.00
NOVAN INC (NOVN) United States $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
Jaguar Animal Health (JAGX) United States $0.023B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
Pain Therapeutics (SAVA) United States $0.019B 0.00
NanoViricides (NNVC) United States $0.018B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.017B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.016B 0.00
Xenetic Biosciences (XBIO) United States $0.015B 0.00
ESSA Pharma (EPIX) Canada $0.014B 0.00
Trillium Therapeutics (TRIL) Canada $0.014B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.013B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.013B 0.00
Regulus Therapeutics (RGLS) United States $0.012B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 3.87
PRECISION THERAPEUTICS INC (AIPT) United States $0.011B 0.00
Can-Fite Biopharma (CANF) Israel $0.011B 0.00
RXi Pharmaceuticals (PHIO) United States $0.011B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.011B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.009B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.008B 0.00
Achaogen (AKAO) United States $0.007B 0.00
Midatech Pharma (MTP) United Kingdom $0.007B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.006B 0.00
VAXART, INC (VXRT) United States $0.006B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00